THIS WARRANT AND THE WARRANT SHARES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. THEY MAY NOT BE OFFERED OR TRANSFERRED BY SALE, ASSIGNMENT, PLEDGE OR OTHERWISE UNLESS (I) SUCH OFFER OR TRANSFER IS MADE PURSUANT TO REGISTRATION UNDER THE...Alpharma Inc • October 30th, 2007 • Pharmaceutical preparations
Alpharma Inc., a Delaware corporation (the "Company"), hereby certifies that IDEA AG, a German aktiengesellschaft, or its registered assigns (the "Registered Holder"), is entitled, subject to the terms and conditions set forth below, to purchase from the Company, at any time or from time to time on or after the Determination Date (as defined below) and on or before 5:00 p.m. (New York City time) on the Termination Date (as defined below), a number of shares of Class A Common Stock, $0.20 par value per share, of the Company ("Common Stock"), determined in accordance with Section 1, at a purchase price per share determined in accordance with Section 1. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the "Warrant Shares" and the "Purchase Price," respectively.
Dated September 4, 2007 IDEA AG - and - ALPHARMA IRELAND LIMITED EXCLUSIVE LICENSE AGREEMENT CONTENTSExclusive License Agreement • October 30th, 2007 • Alpharma Inc • Pharmaceutical preparations • New York
This Exclusive License Agreement ("Agreement") entered into this 4th day of September, 2007 (the "Execution Date"), by and between IDEA AG, a German corporation having an address at Frankfurter Ring 193a, 80807 Munich, Germany (hereinafter referred to as "IDEA") and Alpharma Ireland Limited, an Irish corporation having an address at Arthur Cox Building, Earlsfort Terrace, Dublin 2, Ireland (hereinafter referred to as "ALPHARMA"). IDEA and ALPHARMA are sometimes referred to herein individually as a "Party" and collectively as the "Parties".
March 14, 2007Alpharma Inc • October 30th, 2007 • Pharmaceutical preparations
Alpharma Inc. Alpharma Operating Corporation Alpharma U.S. Inc. Barre Parent Corporation Alpharma Euro Holdings Inc. Alpharma (Bermuda) Inc. Alpharma USHP Inc. Alpharma Animal Health Company Mikjan Corporation Alpharma Holdings Inc. Alpharma Specialty Pharma Inc. Purepac Pharmaceutical Holdings, Inc. Alpharma Branded Products Division Inc. One Executive Drive Fort Lee, New Jersey 07024 Ladies and Gentlemen:
ContractOperation Services Agreement • October 30th, 2007 • Alpharma Inc • Pharmaceutical preparations
Exhibit 10.1 - Confidential Materials Omitted And Filed Separately With The Securities And Exchange Commission. Asterisks Denote Omissions
Alpharma Inc. Registration Rights AgreementRegistration Rights Agreement • October 30th, 2007 • Alpharma Inc • Pharmaceutical preparations • Delaware
This Registration Rights Agreement dated as of October 12, 2007 (this "Agreement"), is entered into between Alpharma Inc., a Delaware corporation (the "Company"), IDEA AG, a German aktiengesellschaft ("IDEA", and the initial "Stockholder"), and any Stockholders who become parties hereto pursuant to Section 2.
ACQUISITION AND CONSTRUCTION AGREEMENTAcquisition and Construction Agreement • October 30th, 2007 • Alpharma Inc • Pharmaceutical preparations
THIS ACQUISITION AND CONSTRUCTION AGREEMENT (the "Agreement") is entered into in Taizhou, China on July 3, 2007 (the "Effective Date") between:
ContractExclusive License and Distribution Agreement • October 30th, 2007 • Alpharma Inc • Pharmaceutical preparations
Exhibit 10.8 - Confidential Materials Omitted And Filed Separately With The Securities And Exchange Commission. Asterisks Denote Omissions
August 24, 2007Alpharma Inc • October 30th, 2007 • Pharmaceutical preparations
Alpharma Inc. Alpharma Operating Corporation Alpharma U.S. Inc. Barre Parent Corporation Alpharma Euro Holdings Inc. Alpharma (Bermuda) Inc. Alpharma USHP Inc. Alpharma Animal Health Company Mikjan Corporation Alpharma Holdings Inc. Alpharma Specialty Pharma Inc. Purepac Pharmaceutical Holdings Inc. Alpharma Pharmaceuticals LLC 440 Route 22 East Bridgewater, New Jersey 08807
October 22, 2007Alpharma Inc • October 30th, 2007 • Pharmaceutical preparations
Alpharma Inc. Alpharma Operating Corporation Alpharma U.S. Inc. Barre Parent Corporation Alpharma Euro Holdings Inc. Alpharma (Bermuda) Inc. Alpharma USHP Inc. Alpharma Animal Health Company Mikjan Corporation Alpharma Holdings Inc. Alpharma Specialty Pharma Inc. Purepac Pharmaceutical Holdings, Inc. Alpharma Pharmaceuticals LLC 440 Route 22 East Bridgewater, New Jersey 08807
ContractLease Agreement • October 30th, 2007 • Alpharma Inc • Pharmaceutical preparations
Exhibit 10.3 - Confidential Materials Omitted And Filed Separately With The Securities And Exchange Commission. Asterisks Denote Omissions
ContractLicense and Distribution Agreement • October 30th, 2007 • Alpharma Inc • Pharmaceutical preparations
Exhibit 10.9 - Confidential Materials Omitted And Filed Separately With The Securities And Exchange Commission. Asterisks Denote Omissions
